Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
1.622
-0.068 (-4.02%)
At close: Nov 7, 2025, 4:00 PM EST
1.650
+0.028 (1.73%)
After-hours: Nov 7, 2025, 7:43 PM EST
Cyclerion Therapeutics Market Cap
Cyclerion Therapeutics has a market cap or net worth of $5.2 million as of November 7, 2025. Its market cap has decreased by -28.04% in one year.
Market Cap
5.20M
Enterprise Value
2.19M
1-Year Change
-28.04%
Ranking
Category
Stock Price
$1.62
Market Cap Chart
Since March 18, 2019, Cyclerion Therapeutics's market cap has decreased from $193.31M to $5.20M, a decrease of -97.31%. That is a compound annual growth rate of -41.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 5.20M | -36.24% |
| Dec 31, 2024 | 8.15M | -0.51% |
| Dec 29, 2023 | 8.19M | -71.30% |
| Dec 30, 2022 | 28.54M | -61.69% |
| Dec 31, 2021 | 74.50M | -28.31% |
| Dec 31, 2020 | 103.92M | 39.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 854.00B |
| Johnson & Johnson | 448.30B |
| AbbVie | 382.09B |
| UnitedHealth Group | 296.77B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 216.23B |
| Novo Nordisk | 215.64B |